Title
Uticaj molekularnih karakteristika invazivnog duktalnog karcinoma dojke na pojavu lokoregionalnih metastaza
Creator
Đorđević, Miodrag, 1989-
CONOR:
38110567
Copyright date
2021
Object Links
Select license
Autorstvo-Nekomercijalno-Bez prerade 3.0 Srbija (CC BY-NC-ND 3.0)
License description
Dozvoljavate samo preuzimanje i distribuciju dela, ako/dok se pravilno naznačava ime autora, bez ikakvih promena dela i bez prava komercijalnog korišćenja dela. Ova licenca je najstroža CC licenca. Osnovni opis Licence: http://creativecommons.org/licenses/by-nc-nd/3.0/rs/deed.sr_LATN. Sadržaj ugovora u celini: http://creativecommons.org/licenses/by-nc-nd/3.0/rs/legalcode.sr-Latn
Language
Serbian
Cobiss-ID
Theses Type
Doktorska disertacija
description
Datum odbrane: 2409.2021.
Other responsibilities
predsednik komisije
Stojanović, Miroslav
član komisije
Janković Veličković, Ljubinka
član komisije
Lončar, Zlatibor
član komisije
Zdravković, Darko
Academic Expertise
Medicinske nauke
University
Univerzitet u Nišu
Faculty
Medicinski fakultet
Group
Katedra za radiologiju, nuklearnu medicinu i osnovi kliničke onkologije
Alternative title
Impact of molecular charachteristics of invasive ductal breast cancer on the occurrence of locoregional metastases
Publisher
[M. N. Đorđević]
Format
127 listova
description
Beleška o autoru: list 127,
Bibliografija: list. 109-126.
description
Surgery
Abstract (en)
Breast cancer (BC) is the most common malignant tumor in female population and the most common cause of death from malignant diseases in women. The most recent literature data have suggested that there is a small population of cancer stem cells, comprising less than 1% of primary tumors, which are responsible for the development of metastases and disease progression. Breast cancer stem cells (BCSCs) have the ability to self-renew and to create a dominant population of cancer cells. The BCSCs phenotype is specific and characterized by the expression of nuclear and membrane pluripotency factors (molecular markers). In this paper we investigated the expression of markers with stem cell properties (KLF4, SOX2, OCT3/4, EZH2, CD44, CD117) in the cancer cells of invasive ductal breast cancer and their association with clinical-pathological parameters and molecular tumor subtype, aiming to evaluate their impact on the occurrence of locoregional matastases. The results of this study showed that tumor size (T4), higher Ki-67 index, high OCT3/4 and EZH2 expression, increased number of highly expressed nuclear markers, and increased number of altered markers were significantly associated with locoregional disease spread. A high expression of OCT3/4 and EZH2 in invasive ductal breast cancer was predictive of axillary metastases. An increased number of metastatic axillary lymph nodes was significantly associated with reduced ER and PR scores, high expression of OCT3/4, EZH2 and SOX2, with an increased number of nuclear markers with high expression, coexpression of all nuclear markers, coexpression of membrane markers CD44 and CD117, and the increased number of altered markers. Coexpression of all nuclear, as well as CD44 and CD117 markers, was predictive of the increased number of metastatic axillary lymph nodes. T4 stage, reduced ER and PR scores, increased expression of OCT3/4, EZH2 and SOX2 had a significant impact on the increased percentage of metastatic axillary lymph nodes, as well as a greater number of nuclear markers with high expression, coexpression of all nuclear markers, coexpression of highly expressed membrane markers, and a greater number of altered markers. Tumor size, increased number of highly expressed nuclear markers, and CD44 and CD117 coexpression were predictive of a greater percentage of metastatic lymph nodes. Since the development of lymphonodal metastases is a key event in the progression of breast cancer, with a deeper knowledge of primary tumor heterogeneity and using standard and new molecular markers, it is important to identify the patients at risk for the development of metastases.
Authors Key words
invazivni duktalni karcinom dojke, lokoregionalne metastaze, ekspresija markera KLF4, SOX2, OCT3/4, EZH2, CD44, CD117
Authors Key words
invasive ductal breast cancer, locoregional metastases, expression of markers KLF4, SOX2, OCT3/4, EZH2, CD44, CD117
Classification
618.19-006.6:616-089(043.3)
Subject
V 600 Surgery, orthopaedics, traumatology
Type
Tekst
Abstract (en)
Breast cancer (BC) is the most common malignant tumor in female population and the most common cause of death from malignant diseases in women. The most recent literature data have suggested that there is a small population of cancer stem cells, comprising less than 1% of primary tumors, which are responsible for the development of metastases and disease progression. Breast cancer stem cells (BCSCs) have the ability to self-renew and to create a dominant population of cancer cells. The BCSCs phenotype is specific and characterized by the expression of nuclear and membrane pluripotency factors (molecular markers). In this paper we investigated the expression of markers with stem cell properties (KLF4, SOX2, OCT3/4, EZH2, CD44, CD117) in the cancer cells of invasive ductal breast cancer and their association with clinical-pathological parameters and molecular tumor subtype, aiming to evaluate their impact on the occurrence of locoregional matastases. The results of this study showed that tumor size (T4), higher Ki-67 index, high OCT3/4 and EZH2 expression, increased number of highly expressed nuclear markers, and increased number of altered markers were significantly associated with locoregional disease spread. A high expression of OCT3/4 and EZH2 in invasive ductal breast cancer was predictive of axillary metastases. An increased number of metastatic axillary lymph nodes was significantly associated with reduced ER and PR scores, high expression of OCT3/4, EZH2 and SOX2, with an increased number of nuclear markers with high expression, coexpression of all nuclear markers, coexpression of membrane markers CD44 and CD117, and the increased number of altered markers. Coexpression of all nuclear, as well as CD44 and CD117 markers, was predictive of the increased number of metastatic axillary lymph nodes. T4 stage, reduced ER and PR scores, increased expression of OCT3/4, EZH2 and SOX2 had a significant impact on the increased percentage of metastatic axillary lymph nodes, as well as a greater number of nuclear markers with high expression, coexpression of all nuclear markers, coexpression of highly expressed membrane markers, and a greater number of altered markers. Tumor size, increased number of highly expressed nuclear markers, and CD44 and CD117 coexpression were predictive of a greater percentage of metastatic lymph nodes. Since the development of lymphonodal metastases is a key event in the progression of breast cancer, with a deeper knowledge of primary tumor heterogeneity and using standard and new molecular markers, it is important to identify the patients at risk for the development of metastases.
“Data exchange” service offers individual users metadata transfer in several different formats. Citation formats are offered for transfers in texts as for the transfer into internet pages. Citation formats include permanent links that guarantee access to cited sources. For use are commonly structured metadata schemes : Dublin Core xml and ETUB-MS xml, local adaptation of international ETD-MS scheme intended for use in academic documents.

